Clinical Trial Update: Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial comparing IDegAsp (insulin degludec/insulin aspart) with separate injections of insulin degludec and insulin aspart in adults with Type 1 diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• IDegAsp (insulin degludec/insulin aspart)
• Insulin aspart (insulin aspart)
• insulin degludec (insulin degludec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED